Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pitolisant, sold under the brand name Wakix among others, is a medication used for the treatment of excessive daytime sleepiness in adults with narcolepsy. It is an inverse agonist of the histamine H3 receptor. It is the first commercially available medication in its class; the U.S. Food and Drug Administration (FDA) designated it a first-in-class…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Pitolisant.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Pitolisant shows recurring relationship patterns in the source. For example, Pitolisant → An, Bioprojet Pharma, Drug Administration, EMA, Europe, European Medicines Agency, European Union, FDA, Food, It, March, NCT01067222, NCT01638403, NCT01800045, South America, The, Trial Another extracted example is Pitolisant → By, CNS, Eugeroics, H3, The H3. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
narcolepsy daytime sleepiness drug excessive effects participants histamine side h3 treatment approved medication activity fda inverse receptor administration trial adults
TTTA extracted 64 structured relationships around Pitolisant. Examples in this analysis include Pitolisant → 3D model (JSmol) → Interactive image and Pitolisant → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pitolisant | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pitolisant | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Pitolisant | ATC code | N07XX11 (WHO) | 1.00 | infobox |
| Pitolisant | Bioavailability | 90 % | 1.00 | infobox |
| Pitolisant | CAS Number | 362665-56-3 N | 1.00 | infobox |
| Pitolisant | CAS Number | HCl: 903576-44-3 N | 1.00 | infobox |
| Pitolisant | ChEBI | CHEBI:134709 Y | 1.00 | infobox |
| Pitolisant | ChEMBL | ChEMBL462605 Y | 1.00 | infobox |
| Pitolisant | ChemSpider | 8123714 Y | 1.00 | infobox |
| Pitolisant | ChemSpider | HCl: 9726467 | 1.00 | infobox |
| Pitolisant | CompTox Dashboard (EPA) | DTXSID30957654 | 1.00 | infobox |
| Pitolisant | Drug class | Histamine H3 receptor inverse agonist | 1.00 | infobox |
| Pitolisant | DrugBank | DB11642 | 1.00 | infobox |
| Pitolisant | DrugBank | HCl: DBSALT002888 | 1.00 | infobox |
| Pitolisant | Elimination half-life | 10–12 hours | 1.00 | infobox |
| Pitolisant | Formula | C17H26ClNO | 1.00 | infobox |
| Pitolisant | KEGG | D10749 N | 1.00 | infobox |
| Pitolisant | KEGG | HCl: D11490 N | 1.00 | infobox |
| Pitolisant | Legal status | CA: ℞-only | 1.00 | infobox |
| Pitolisant | Legal status | US: ℞-only | 1.00 | infobox |
| Pitolisant | Legal status | EU: Rx-only | 1.00 | infobox |
| Pitolisant | License data | US DailyMed: Pitolisant | 1.00 | infobox |
| Pitolisant | MedlinePlus | a619055 | 1.00 | infobox |
| Pitolisant | Metabolism | CYP2D6, CYP3A4 | 1.00 | infobox |
| Pitolisant | Molar mass | 295.85 g·mol−1 | 1.00 | infobox |
| Pitolisant | Other names | Tiprolisant; Ciproxidine; BF2.649 | 1.00 | infobox |
| Pitolisant | Pronunciation | /pɪˈtɒlɪsənt/ pi-TOL-i-sənt | 1.00 | infobox |
| Pitolisant | Protein binding | 91-96 % | 1.00 | infobox |
| Pitolisant | PubChem CID | 9948102 | 1.00 | infobox |
| Pitolisant | Routes of administration | By mouth | 1.00 | infobox |
The concept neighborhoods around Pitolisant bring nearby vocabulary together. In this analysis, examples include Narcolepsy, Drug and Participants. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Pitolisant, one of the stronger structural bridges in this analysis connects Pitolisant with Side effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Pitolisant to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Pitolisant · EN edition · Analysis: TopicsToTalkAbout